comparemela.com

Latest Breaking News On - Hikma pharmaceuticals trading - Page 1 : comparemela.com

Hikma Pharmaceuticals (OTCMKTS:HKMPY) Stock Price Up 1.8%

Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) rose 1.8% during mid-day trading on Tuesday . The company traded as high as $44.60 and last traded at $44.60. Approximately 484 shares changed hands during trading, a decline of 53% from the average daily volume of 1,033 shares. The stock had previously closed at […]

United-states
America
Hikma-pharmaceuticals
Hikma-pharmaceuticals-company-profile
News-ratings-for-hikma-pharmaceuticals-daily
Hikma-pharmaceuticals-trading
Get-free-report
North-america
Middle-east
North-africa
Hikma-pharmaceuticals-daily

Hikma Pharmaceuticals PLC (LON:HIK) Receives GBX 1,972.50 Consensus Target Price from Analysts

Hikma Pharmaceuticals PLC (LON:HIK) Receives GBX 1,972.50 Consensus Target Price from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
America
Royal-bank
Analyst-recommendations-for-hikma-pharmaceuticals
Citigroup
Hikma-pharmaceuticals
News-ratings-for-hikma-pharmaceuticals-daily
Jpmorgan-chase-co
Hikma-pharmaceuticals-trading
Get-free-report

Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) Target Price at GBX 1,939.17

Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective […]

United-states
America
Analyst-recommendations-for-hikma-pharmaceuticals
News-ratings-for-hikma-pharmaceuticals-daily
Barclays
Jefferies-financial-group
Hikma-pharmaceuticals-cuts-dividend
Hikma-pharmaceuticals-trading
Hikma-pharmaceuticals
Get-free-report
Financial-group

Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) Target Price at GBX 1,922.50

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have been given an average rating of “Moderate Buy” by the six brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target […]

Canada
Berenberg-bank
Hikma-pharmaceuticals-trading
Jefferies-financial-group
Hikma-pharmaceuticals
Royal-bank
Analyst-recommendations-for-hikma-pharmaceuticals
News-ratings-for-hikma-pharmaceuticals-daily
Barclays
Jpmorgan-chase-co
Get-rating

Hikma Pharmaceuticals (LON:HIK) Reaches New 52-Week High at $1,915.50

Hikma Pharmaceuticals PLC (LON:HIK – Get Rating)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 1,915.50 ($24.17) and last traded at GBX 1,875.50 ($23.67), with a volume of 33604 shares trading hands. The stock had previously closed at GBX 1,874 ($23.65). Wall Street Analysts […]

Canada
Royal-bank
Barclays
Jpmorgan-chase-co
Jefferies-financial-group
Hikma-pharmaceuticals
Hikma-pharmaceuticals-increases-dividend
Hikma-pharmaceuticals-trading
News-ratings-for-hikma-pharmaceuticals-daily
Citigroup
Get-rating

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.